Wang, Yashi <br/><br/>
A dual receptors-targeting and size-switchable "cluster bomb" co-loading chemotherapeutic and transient receptor potential ankyrin 1 (TRPA-1) inhibitor for treatment of triple negative breast cancer.  [electronic resource] 

 -  Journal of controlled release : official journal of the Controlled Release Society  05 2020 
 - 71-83 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-4995 
<br/><br/><label>Standard No.: </label>10.1016/j.jconrel.2020.02.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Ankyrins<br/>Cell Line, Tumor<br/>Doxorubicin<br/>Drug Carriers<br/>Humans<br/>Mice<br/>Micelles<br/>TRPA1 Cation Channel--antagonists & inhibitors<br/>Triple Negative Breast Neoplasms--drug therapy